CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome.

MLA

Raghavakaimal, Ashvathi, et al. “CCR5 Activation and Endocytosis in Circulating Tumor-Derived Cells Isolated from the Blood of Breast Cancer Patients Provide Information about Clinical Outcome.” Breast Cancer Research, vol. 24, no. 1, May 2022, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s13058-022-01528-w.

APA

Raghavakaimal, A., Cristofanilli, M., Tang, C.-M., Alpaugh, R. K., Gardner, K. P., Chumsri, S., & Adams, D. L. (2022). CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome. Breast Cancer Research, 24(1), 1–12. https://doi.org/10.1186/s13058-022-01528-w

Chicago

Raghavakaimal, Ashvathi, Massimo Cristofanilli, Cha-Mei Tang, R. K. Alpaugh, Kirby P. Gardner, Saranya Chumsri, and Daniel L. Adams. 2022. “CCR5 Activation and Endocytosis in Circulating Tumor-Derived Cells Isolated from the Blood of Breast Cancer Patients Provide Information about Clinical Outcome.” Breast Cancer Research 24 (1): 1–12. doi:10.1186/s13058-022-01528-w.